ClinicalTrials.govpublic full text
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
papillary thyroid cancer, follicular thyroid cancer, huerthle cell thyroid cancer, renal cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 201718
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.